Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis
The use of dimethyl fumarate (DMF) in the treatment of children with paediatric-onset multiple sclerosis (POMS) appears to produce more favourable effects than interferon β-1a (IFNβ-1a), with those on DMF being less likely to have new or newly enlarging lesions and experience relapse, according to data from the open-label CONNECT study.
Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis
10 Oct 2022
HBsAg seroclearance tied to lower recurrence risk of HBV-related hepatocellular carcinoma
Hepatitis B surface antigen (HBsAg) seroclearance appears to reduce the risk of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) late recurrence among patients who underwent curative liver resection, results of a Korea study have shown.
HBsAg seroclearance tied to lower recurrence risk of HBV-related hepatocellular carcinoma
10 Oct 2022
Krill oil relieves pain in adults with knee osteoarthritis
Krill oil supplement is not only safe to consume but also modestly improves knee pain, stiffness, and physical function in adults with mild to moderate knee osteoarthritis (OA), reveals a study.
Krill oil relieves pain in adults with knee osteoarthritis
10 Oct 2022
Pan-enteric capsule endoscopy accurately diagnoses IBD
The use of pan-enteric capsule endoscopy (PCE) leads to high diagnostic yield for inflammatory bowel diseases (IBDs), often even matching that of colonoscopy and magnetic resonance enterography (MRE), reports a recent meta-analysis.
Pan-enteric capsule endoscopy accurately diagnoses IBD
10 Oct 2022
Boys born to moms with GDM at risk of neurodevelopmental delays
Neurodevelopment appears to be significantly delayed at up to 4 years of age in boys who are born to mothers with gestational diabetes mellitus (GDM), reports a recent study.
Boys born to moms with GDM at risk of neurodevelopmental delays
10 Oct 2022
SGLT2i does not worsen lower-limb amputation risk
Among patients with type 2 diabetes (T2D), the use of sodium-glucose cotransporter 2 inhibitors {SGLT2i) does not appear to increase the risk of lower-limb amputation, a recent study has found.
